Expansion of hMSCs and Their Application

Zhidao Xia, Joanna Bishop

Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

1 Citation (Scopus)

Abstract

Human mesenchymal stem cells (hMSCs) can generate bone, cartilage, tendon, muscle, ligament, fat, and are able to differentiate to cardiomyocytes, neurons and astrocytes, etc. in defined conditions. They not only differentiate to the cell type required for local tissue regeneration, but also secrete a large number of bioactive molecules following implantation that ultimately lead to reformation of tissues at the site of injury. The hMSCs can be isolated with consent from bone marrow, adipose tissue, dental pulp, umbilical cord blood and matrix, and potentially peripheral blood. They have been widely used for clinical application without the ethical issues implicated with embryonic stem cells. However, they are a rare population in bone marrow and other tissues. In order to reach the number required for clinical use, they need to be expanded significantly in vitro. A variety of biotechnologies are applied for hMSC expansion, including static culture by using tissue culture flasks and cell factory and gas-permeable blood bags; or dynamic culture by using spinner flasks, stirred or rotary bioreactors with/without three-dimensional cell carriers. Routine quality controls are essential to avoid contamination, ensure stable phenotype, and monitor cell mutation before clinical applications.
Original languageEnglish
Title of host publicationComprehensive Biotechnology
PublisherPergamon
Pages426-436
Number of pages11
Volume5
Edition2
ISBN (Electronic)9780080885049
ISBN (Print)9780444533524
DOIs
Publication statusPublished - 9 Sep 2011
Externally publishedYes

Fingerprint

Mesenchymal Stromal Cells
Bone Marrow
Dental Pulp
Bioreactors
Embryonic Stem Cells
Biotechnology
Fetal Blood
Ligaments
Cardiac Myocytes
Ethics
Astrocytes
Quality Control
Tendons
Cartilage
Adipose Tissue
Regeneration
Cell Culture Techniques
Gases
Fats
Phenotype

Cite this

Xia, Z., & Bishop, J. (2011). Expansion of hMSCs and Their Application. In Comprehensive Biotechnology (2 ed., Vol. 5, pp. 426-436). Pergamon. https://doi.org/10.1016/B978-0-08-088504-9.00504-3
Xia, Zhidao ; Bishop, Joanna . / Expansion of hMSCs and Their Application. Comprehensive Biotechnology. Vol. 5 2. ed. Pergamon, 2011. pp. 426-436
@inbook{6175051f175345808248553e0c2ef1fc,
title = "Expansion of hMSCs and Their Application",
abstract = "Human mesenchymal stem cells (hMSCs) can generate bone, cartilage, tendon, muscle, ligament, fat, and are able to differentiate to cardiomyocytes, neurons and astrocytes, etc. in defined conditions. They not only differentiate to the cell type required for local tissue regeneration, but also secrete a large number of bioactive molecules following implantation that ultimately lead to reformation of tissues at the site of injury. The hMSCs can be isolated with consent from bone marrow, adipose tissue, dental pulp, umbilical cord blood and matrix, and potentially peripheral blood. They have been widely used for clinical application without the ethical issues implicated with embryonic stem cells. However, they are a rare population in bone marrow and other tissues. In order to reach the number required for clinical use, they need to be expanded significantly in vitro. A variety of biotechnologies are applied for hMSC expansion, including static culture by using tissue culture flasks and cell factory and gas-permeable blood bags; or dynamic culture by using spinner flasks, stirred or rotary bioreactors with/without three-dimensional cell carriers. Routine quality controls are essential to avoid contamination, ensure stable phenotype, and monitor cell mutation before clinical applications.",
author = "Zhidao Xia and Joanna Bishop",
year = "2011",
month = "9",
day = "9",
doi = "10.1016/B978-0-08-088504-9.00504-3",
language = "English",
isbn = "9780444533524",
volume = "5",
pages = "426--436",
booktitle = "Comprehensive Biotechnology",
publisher = "Pergamon",
edition = "2",

}

Xia, Z & Bishop, J 2011, Expansion of hMSCs and Their Application. in Comprehensive Biotechnology. 2 edn, vol. 5, Pergamon, pp. 426-436. https://doi.org/10.1016/B978-0-08-088504-9.00504-3

Expansion of hMSCs and Their Application. / Xia, Zhidao; Bishop, Joanna .

Comprehensive Biotechnology. Vol. 5 2. ed. Pergamon, 2011. p. 426-436.

Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

TY - CHAP

T1 - Expansion of hMSCs and Their Application

AU - Xia, Zhidao

AU - Bishop, Joanna

PY - 2011/9/9

Y1 - 2011/9/9

N2 - Human mesenchymal stem cells (hMSCs) can generate bone, cartilage, tendon, muscle, ligament, fat, and are able to differentiate to cardiomyocytes, neurons and astrocytes, etc. in defined conditions. They not only differentiate to the cell type required for local tissue regeneration, but also secrete a large number of bioactive molecules following implantation that ultimately lead to reformation of tissues at the site of injury. The hMSCs can be isolated with consent from bone marrow, adipose tissue, dental pulp, umbilical cord blood and matrix, and potentially peripheral blood. They have been widely used for clinical application without the ethical issues implicated with embryonic stem cells. However, they are a rare population in bone marrow and other tissues. In order to reach the number required for clinical use, they need to be expanded significantly in vitro. A variety of biotechnologies are applied for hMSC expansion, including static culture by using tissue culture flasks and cell factory and gas-permeable blood bags; or dynamic culture by using spinner flasks, stirred or rotary bioreactors with/without three-dimensional cell carriers. Routine quality controls are essential to avoid contamination, ensure stable phenotype, and monitor cell mutation before clinical applications.

AB - Human mesenchymal stem cells (hMSCs) can generate bone, cartilage, tendon, muscle, ligament, fat, and are able to differentiate to cardiomyocytes, neurons and astrocytes, etc. in defined conditions. They not only differentiate to the cell type required for local tissue regeneration, but also secrete a large number of bioactive molecules following implantation that ultimately lead to reformation of tissues at the site of injury. The hMSCs can be isolated with consent from bone marrow, adipose tissue, dental pulp, umbilical cord blood and matrix, and potentially peripheral blood. They have been widely used for clinical application without the ethical issues implicated with embryonic stem cells. However, they are a rare population in bone marrow and other tissues. In order to reach the number required for clinical use, they need to be expanded significantly in vitro. A variety of biotechnologies are applied for hMSC expansion, including static culture by using tissue culture flasks and cell factory and gas-permeable blood bags; or dynamic culture by using spinner flasks, stirred or rotary bioreactors with/without three-dimensional cell carriers. Routine quality controls are essential to avoid contamination, ensure stable phenotype, and monitor cell mutation before clinical applications.

U2 - 10.1016/B978-0-08-088504-9.00504-3

DO - 10.1016/B978-0-08-088504-9.00504-3

M3 - Chapter

SN - 9780444533524

VL - 5

SP - 426

EP - 436

BT - Comprehensive Biotechnology

PB - Pergamon

ER -

Xia Z, Bishop J. Expansion of hMSCs and Their Application. In Comprehensive Biotechnology. 2 ed. Vol. 5. Pergamon. 2011. p. 426-436 https://doi.org/10.1016/B978-0-08-088504-9.00504-3